Gå direkt till huvudinnehållet

Spontanabort

Senast uppdaterad: Publicerad:
Sakkunnig:
  1. Griebel CP, Halvorsen J, Golemon TB, Day AA. Management of spontaneous abortion. Am Fam Physician 2005; 72: 1243-50. PubMed  
  2. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ 1997; 315: 32-4. British Medical Journal  
  3. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319: 189-94. New England Journal of Medicine  
  4. Magnus MC, Wilcox AJ, Morken N-H, et al. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ 2019; 364: l869. pmid:30894356 PubMed  
  5. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999; 14:2868-71. PubMed  
  6. Goddijn M, Leschot NJ. Genetic aspects of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 855-65. PubMed  
  7. Gravida - råd om bra mat. Livsmedelsverket 2020 www.livsmedelsverket.se  
  8. Li D-K, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory durgs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003; 327: 368. PubMed  
  9. Nakhai-Pour HR, Broy P, Sheehy O, Bérard A. Use of nonaspirin nonsteroidal anti-infalmmatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ 2011; 183:1713-20. Canadian Medical Association Journal  
  10. Sosa CG, Althabe F, Belizán JM, et al. Bed rest in singleton pregnancies for preventing preterm birth. Cochrane Database Syst Rev. 2015 Mar 30;3:CD003581. doi: 10.1002/14651858.CD003581.pub3. DOI  
  11. La Marca A, Morgante G, De Leo V. Human chorionic gonadotrophin, thyroid function, and immunological indices in threatened abortion. Obstet Gynecol 1998; 92: 206-11. PubMed  
  12. al-Sebai MA, Diver M, Hipkin LJ. The role of a single free beta-human chorionic gonadotrophin measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. Hum Reprod 1996; 11: 881-8. PubMed  
  13. Oslo universitetssykehus, eHåndbok: Abort, medisinsk og kirurgisk behandling av spontan- og missed abortion samt blighted ovum. Prosedyre. Siden besøkt 02.11.2021. ehandboken.ous-hf.no  
  14. Stovall TG, Ling FW, Andersen RN, Buster JE. Improved sensitivity and specificity of a single measurement of serum progesterone over serial quantitative beta-human chorionic gonadotrophin in screening for ectopic pregnancy. Hum Reprod 1992; 7:723-5. PubMed  
  15. al-Sebai MA, Kingsland CR, Diver M, Hipkin L, McFadyen IR. The role of a single progesterone measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability. Br J Obstet Gynaecol 1995; 102: 364-9. PubMed  
  16. Florio P, Luisi S, D'Antona D, Severi FM, Rago G, Petraglia F. Maternal serum inhibin A levels may predict pregnancy outcome in women with threatened abortion. Fertil Steril 2004; 81: 468-70. PubMed  
  17. Fiegler P, Katz M, Kaminski K, Rudol G. Clinical value of a single serum CA-125 level in women with symptoms of imminent abortion during the first trimester of pregnancy. J Reprod Med 2003; 48: 982-8. PubMed  
  18. Falco P, Zagonari S, Gabrielli S, Bevini M, Pilu G, Bovicelli L. Sonography of pregnancies with first-trimester bleeding and a small intrauterine gestational sac without a demonstrable embryo. Ultrasound Obstet Gynecol 2003; 21: 62-5. PubMed  
  19. Tongsong T, Wanapirak C, Srisomboon J, Sirichotiyakul S, Polsrisuthikul T, Pongsatha S. Transvaginal ultrasound in threatened abortions with empty gestational sacs. Int J Gynaecol Obstet 1994; 46: 297-301. PubMed  
  20. Everett CB, Preece E. Women with bleeding in the first 20 weeks of pregnancy: value of general practice ultrasound in detecting fetal heart movement. Br J Gen Pract 1996; 46: 7-9. PubMed  
  21. Makrydimas G, Sebire NJ, Lolis D, Vlassis N, Nicolaides KH. Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation. Ultrasound Obstet Gynecol 2003; 22: 368-72. PubMed  
  22. Reljic M. The significance of crown-rump length measurement for predicting adverse pregnancy outcome of threatened abortion. Ultrasound Obstet Gynecol 2001; 17: 510-2. PubMed  
  23. Ankum WM, deWaard MW, Bindels PJE. Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. Review . BMJ 2001; 322: 1343-6. PubMed  
  24. Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ 2006; 332: 1235-8. British Medical Journal  
  25. Nguyen TNN, Blum J, Durocher J, Quan TTVQ, Winikoff B. A randomized controlled study comparing 600 versus 1200 µg oral misoprostol for medical management of incomplete abortion. Contraception 2005; 72: 438-42. PubMed  
  26. Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM for the National Institute of Child Health Human Development (NICHD) Management of Early Pregnancy Failure Trial. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med 2005; 353: 761-9. New England Journal of Medicine  
  27. Schreiber CA, Creinin MD, Atrio J, et al. Mifepristone Pretreatment for the Medical Management of Early Pregnancy Loss. N Engl J Med 2018; 378: 2161-70. pmid:29874535 PubMed  
  28. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001; 344: 38-47. New England Journal of Medicine  
  29. Blanchard, K, Taneepanichskul S, Kiriwat O, et al. Two regimens of misoprostol for treatment of incomplete abortion. Obstet Gynecol 2004; 103: 860-65. PubMed  
  30. Murchison A, Duff P. Misoprostol for uterine evacuation in patients with early pregnancy failures. Am J Obstet Gynecol 2004; 190: 1445-6. PubMed  
  31. Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med 2005; 353: 761-9. New England Journal of Medicine  
  32. Winikoff B. Pregnancy failure and misoprostol - time for a change. N Engl J Med 2005; 353: 834-6. PubMed  
  33. Davis AR, Hendlish SK, Westhoff C, et al. Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial. Am J Obstet Gynecol 2007; 196: 31. PubMed  
  34. Neilson J, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database Syst Rev 2006; 3: CD002253. Cochrane (DOI)  
  35. Sotiriadis A, Makrydimas G, Papatheodorou S, Ioannidis JP. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis. Obstet Gynecol 2005; 105: 1104-13. PubMed  
  36. Forna F, Gulmezoglu AM. Surgical procedures to evacuate incomplete abortion (Cochrane Review). In: The Cochrane Library, Issue 1, 2001. Oxford: Update Software. The Cochrane Library  
  37. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. The Cochrane Database of Systematic Reviews 2006, Issue 2. The Cochrane Library  
  38. Love E, Bhattacharya S, et.al. Effect of interpregnancy interval on outcomes of pregnancy after miscarriage: retrospective analysis of hospital episode statistics in Scotland. BMJ 2010; 341: c3967. BMJ (DOI)  
  39. Smith LFP, Ewings PD, Quinlan C. Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long term follow-up of miscarriage treatment (MIST) randomised controlled trial. BMJ 20009; 339: b3827. PubMed  
  40. Johns J, Hyett J, Jauniaux E. Obstetric outcome after threatened miscarriage with and without a hematoma on ultrasound. Obstet Gynecol 2003; 102: 483-7. PubMed  
  • Britt Friberg, docent och överläkare, Reproduktionsmedicinskt Centrum, Malmö, och Kvinnokliniken, Skånes universitetssjukhus

Tidigare sakkunniga

  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim
  • Per Bergsjø, professor emeritus, dr. med., Universitetet i Bergen. Specialist i kvinnosjukdomar och förlossningshjälp, forskare vid Nasjonalt folkehelseinstitutt, Oslo
  • Åsa Rytter Evensen, specialist i allmänmedicin, Røa Helsesenter, Oslo kommun
  • Inger Marie Steinsholt, specialist i allmänmedicin, A/S Legekontoret, Kongsberg